With coronavirus cases emerging at a modest rate in Los Angeles County, health officials say it’s a good idea to take steps to protect against infection.
Doctors noted that the infection continues to pose a long-term COVID risk, in which symptoms of the disease can persist for years and put other people at higher long-term risk for diabetes and central disease.
Here are some tips for staying safe during spring break, Easter, and the Coachella Valley Music and Arts Festival:
There are still many other people in L. A. County. who are eligible for their first reinforcement but have not yet received the reinforcement.
Among those at highest risk, only 74% of other people over the age of 65 who were vaccinated and eligible for a booster gained their first booster; the same is true for only 65% of vaccinated adults between the ages of 50 and 64, according to knowledge shared through Los Angeles County Public Health Director Barbara Ferrer.
The U. S. Centers for Disease Control and PreventionU. S. Citizens recommend that those over the age of 12 get at least one COVID-19 booster vaccine after completing the number one round of vaccination.
People over the age of 50 are eligible for a momentary booster shot, as are immunocompromised people over the age of 12.
Yes, that may just be a problem. But asking other people about their reputation for vaccination and booster is especially when other people at higher risk of COVID-19 headaches attend an event.
Goldenvoice has cancelled all COVID-19 protection protocols for the Coachella and Stagecoach country-themed festivals to be held later this month in Indio.
Some other people dismiss their symptoms as allergy-related, but that may just be COVID-19.
Get checked and, regardless of the outcome of the check, stay home if you are sick. Sometimes, immediate verifications can show negative verification effects when there are too few viruses in the frame to be detected through verification; waiting more days may show a positive verification result later.
“If you have symptoms, if you have a positive test, you need to start employing virtual methods to connect again, so that you can convey joy, but you’re not spreading the virus,” Ferrer said.
If you’re moving on to be around other people with a higher threat of serious illness, Ferrer said, “it’s vital to go ahead and get this COVID-19 test before you meet them. “
And if you think you were exposed to the coronavirus after your meeting, get tested after the event, Ferrer said.
“Someone I know took immediate COVID before visiting a highly immunocompromised person. They were asymptomatic other than ‘allergy symptoms,'” Dr. Jeremy Faust, an emergency physician at Brigham and Women’s Hospital and an instructor at the School, tweeted. of Medicine from Harvard.
“The verification was done only to protect the user at risk. It’s positive,” wrote Faust. La rapid screening of other asymptomatic people saves lives. “
Rapid coronavirus home tests can be purchased at pharmacies and retail stores.
Insured Americans also have the option to request 8 internal tests per month for the covered user through their fitness plan and receive reimbursement through their fitness service provider. The U. S. government The U. S. Department of Health began requiring insurance companies to reimburse those tests starting in mid-January.
In addition, each and every family in the United States is eligible to get two sets of 4 free home trials. Individuals can request such tests at covidtests. gov or by calling (800) 232-0233. Many other people ordered their first test circular in January or February; the government allowed families to request a circular moment of loose testing in March.
Keeping gatherings outdoors reduces the threat of infection, Ferrer said.
“When it’s not possible, it’s better for meetings to be small. And you can flow the indoor air by opening windows, doors and employing enthusiasts strategically,” Ferrer said.
Although it is no longer mandatory, Ferrer and state fitness officials have continued to bet strongly on the use of a mask in closed public places. Respirators, such as KF94, KN95 and N95 masks, are offering greater protection.
Anti-COVID medications are available to those who test positive and are at increased risk, but it’s important that you know your reputation for coronavirus control at the beginning of infection and test medications quickly.
For other people who test positive, state health officials say there is no longer a shortage of COVID medicines in most places.
“For now, all outpatients with mild to moderate COVID-19 who are at risk of disease progression will receive treatment, if eligible,” the California Department of Public Health said recently. People can get prescriptions by calling their physical care provider.
The U. S. government The U. S. Department of Health has introduced a “Test to Treat” program, which allows other people to check on and get loose COVID pills in a place, such as a pharmacy or clinic, as long as they can perform a coronavirus test or compare a test result at home and have health care providers on site who can evaluate the patient.
A list of sites that provide “Test to Treat” can be found in Los Angeles County in ph. lacounty. gov/covidmedicines or by calling the county’s public fitness branch at (833) 540-0473, between 8 a. m. m. and 8:30 p. m. , seven days a week. week. They come with some CVS and Walgreens sites, as well as local hospitals, clinics, and pharmacies. An L. A. County resident who tests positive can also get the medication in the mail free of charge by calling the same number.
For an L. A. County resident, “If you have a home verification kit and you are testing positive, you can call us. We will ask a provider or doctor to talk to you about an evaluation. If you’re eligible, you’ll get this medication overnight so you have it the next day,” Ferrer said.
“Test to Treat” sites outside of Los Angeles County are in aspr. hhs. gov/TestToTreat.
The antiviral pills featured in the program are Paxlovid, manufactured through Pfizer, and molnupiravir, manufactured through Merck.
According to federal guidelines, Paxlovid and molnupiravir are for patients “at the greatest threat of progression to severe COVID-19,” but can only be given to those who are not so sick that require hospitalization or additional oxygen treatment.
Another drug that is not part of the “Test to Treat” program, but is not yet available as an anti-COVID drug, is bebtélovimab, which belongs to a class of drugs called monoclonal antibodies.
Bebtélovimab is intended for other people 12 years of age and older who have tested positive for the coronavirus, who are at higher risk and for whom other characteristics of treatment are not available or appropriate. It should also be given by injection for at least 30 minutes.
Another COVID-19 drug, remdesivir, is given intravenously, but it belongs to the class of drugs called antivirals.
Remdesivir is given intravenously as a slow infusion of 30 minutes to two hours in a hospital. For non-hospitalized patients, it is administered once a day for 3 days and is started within seven days of the first symptoms; for hospitalized patients with severe COVID-19, it is given once a day for five to 10 days.
Unlike anti-COVID drugs that are obtained in tablet form, remdesivir is the only antiviral that can be used to treat children under the age of 12, as long as they weigh at least 7. 7 pounds.
The U. S. Food and Drug Administrationhas stated that his preferred treatments are first Paxlovid and then remdesivir. When it can’t be obtained or used, the FDA says you can think of bebtelovimab and molnupiravir as alternatives.
Follow
Rong-Gong Lin II is a San Francisco-based subway reporter who specializes in covering safety issues opposed to statewide earthquakes and the COVID-19 pandemic. The Bay Area local graduated from UC Berkeley and the Los Angeles Times in 2004.
Follow
Luke Money is a Metro reporter who covers the latest news in the Los Angeles Times. In the past he was a city reporter and deputy editor for the Daily Pilot, a Times Community News publication in Orange County, and prior to that, he wrote for the Santa Clarita Valley Signal. She earned her bachelor’s degree in journalism from the University of Arizona.
Subscribers read
Subscribe to access
Follow